Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $5.29 -0.12 (-2.22%) Closing price 03:50 PM EasternExtended Trading$5.34 +0.05 (+0.95%) As of 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Eupraxia Pharmaceuticals Stock Price Performance The Eupraxia Pharmaceuticals (EPRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 111.60%, with a year-to-date return of 66.88%. In the past month, the stock has increased 24.76%, reflecting recent market activity. As of the latest close, Eupraxia Pharmaceuticals traded at $5.41 with a market cap of $194.54 million and volume of 3,484 shares. Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.74%1 Month Performance+24.76%3 Month Performance+59.82%Year-To-Date Performance+66.88%1 Year Performance+111.60% EPRX Stock Chart for Friday, July, 18, 2025 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$5.41$5.29-2.22%$5.38$5.264,195 shs$190.23 million07/17/2025$5.35$5.41+1.12%$5.47$5.303,484 shs$194.54 million07/16/2025$5.35$5.35+0.02%$5.60$5.3512,275 shs$192.37 million07/15/2025$5.59$5.35-4.31%$5.61$5.383,393 shs$192.35 million07/14/2025$5.44$5.59+2.78%$5.64$5.3122,873 shs$201.02 million07/11/2025$5.57$5.44-2.37%$5.54$5.365,792 shs$195.59 million07/10/2025$5.46$5.57+2.03%$5.68$5.493,595 shs$200.32 million07/09/2025$5.59$5.46-2.33%$5.66$5.4610,877 shs$196.34 million07/08/2025$5.54$5.59+0.92%$5.90$5.3910,733 shs$201.02 million07/07/2025$5.47$5.54+1.35%$5.67$5.396,820 shs$199.18 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$5.47$5.47$5.74$5.308,647 shs$196.52 million07/03/2025$5.47$5.47-0.09%$5.74$5.308,647 shs$196.51 million07/02/2025$5.84$5.47-6.34%$5.75$5.3912,256 shs$196.70 million07/01/2025$5.76$5.84+1.39%$6.20$5.8221,918 shs$210.01 million06/30/2025$5.30$5.76+8.68%$5.90$5.3028,210 shs$207.13 million06/27/2025$4.62$5.30+14.72%$5.43$4.6727,059 shs$190.59 million06/26/2025$4.31$4.62+7.19%$4.68$4.406,013 shs$166.14 million06/25/2025$4.35$4.31-0.92%$4.49$4.312,977 shs$154.99 million06/24/2025$4.38$4.35-0.68%$4.41$4.333,972 shs$156.43 million06/23/2025$4.32$4.38+1.39%$4.41$4.1915,007 shs$157.49 million06/20/2025$4.24$4.32+1.89%$4.49$4.2210,162 shs$155.35 million06/19/2025$4.24$4.24$4.33$4.224,922 shs$152.47 million06/18/2025$4.27$4.24-0.70%$4.33$4.224,922 shs$152.46 million06/17/2025$4.17$4.27+2.40%$4.36$4.1222,495 shs$153.54 million Related Companies Cronos Group Stock Chart uniQure Stock Chart Oculis Stock Chart AnaptysBio Stock Chart BGM Group Stock Chart CorMedix Stock Chart Vir Biotechnology Stock Chart KalVista Pharmaceuticals Stock Chart Amylyx Pharmaceuticals Stock Chart ArriVent BioPharma Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EPRX Stock Alerts